Results: IL2 was usually not detectable in any of the disease groups.
2
Conclusions: IL2Ra could be safely and effectively used after liver transplantation in various situations.
3
The regimen included neither lymphocyte-depleting conditioning nor administration of IL2.
4
Under these conditions, rH-IL2 alone activated macrophages to a tumoricidal state in a concentration dependent fashion.
5
Among low-risk recipients with low-risk donors there was no difference in outcomes between IL2RA and rATG.
6
The aim of this study was to present our strategy for IL2Ra rescue therapy and its outcome.
7
Among low-risk recipients with high-risk donors, there was a trend toward a higher risk of death with IL2RA.
8
Targeted exon sequencing identified rare variants in IL2RA and IL2RB associated with rheumatoid arthritis.
9
Lower IL2RA levels consistently originated from the T1D predisposing allele.
10
These data suggest that rH-IL2-induced peritoneal macrophage activation requires stimulation of nonadherent cells and is dependent upon gamma-interferon mediated mechanisms.
11
Each cycle of therapy was associated with induction of eosinophilia as well as an increase in serum soluble IL2 receptor.
12
The back-up is the council admin building which is 17 percent NBS (IL2).
13
These data also confirm that growth failure in X-SCID is primarily related to the genetic alteration of the IL2RG gene.
14
Results: In high-risk recipients with high-risk donors there was a higher risk of rejection and functional graft loss with IL2RA versus rATG.
15
In animal systems, complete and permanent eradication of tumours can be achieved by adoptive transfer of MHC-restricted T cells, combined with IL2.
16
Ex vivo and in vitro studies with human and primate T cells show that pembrolizumab enhances antigen-specific T-cell IFNγ and IL2 production.